AI Terminal
Chemring Group PLC
Share Issue/Capital Change • Dec 22, 2020
5264_rns_2020-12-22_fc72d3aa-249a-42d2-8bc9-a01e6e5fb5ce.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 5689J
Chemring Group PLC
22 December 2020
22 December 2020
Correction to the announcement made at 13:08 (RNS number: 5618J) on 22/12/2020: The expected date of admission will be 6 January 2021 and not 6 January 2020 as previously announced. The full corrected announcement is as per below. All other information was correct:
Chemring Group PLC ("the Company")
Additional Listing
An application has been made to the UK Financial Conduct Authority and to the London Stock Exchange for a blocklisting of 812,457 ordinary shares of 1p each in the Company ("Ordinary Shares") to be admitted to the Official List and to trading on the London Stock Exchange's market for listed securities ("Admission").
The new Ordinary Shares, which will rank pari passu with the existing ordinary shares in issue, may be issued pursuant to the exercise of 812,457 employee share options granted under The Chemring Group 2018 UK Sharesave Plan on 30 July 2020. It is expected that Admission will become effective and that dealings in the Ordinary Shares will commence on 6 January 2021.
For further information:
| Chemring Group PLC | ||
| Sarah Ellard | Group Legal Director | +44 (0)1794 833 901 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSUUSORRVUUUAA